NCT05491967View on ClinicalTrials.gov

Comparison of Vascular Risk in Patients Treated for Obstructive Sleep Apnea/Hypopnea Syndrome

CompletedOBSERVATIONAL
Enrollment

172

Participants

Timeline

Start Date

March 16, 2021

Primary Completion Date

March 16, 2022

Study Completion Date

March 16, 2023

Conditions
Obstructive Sleep Apnea/Hypopnea Syndrome
Trial Locations (1)

26953

Ch Valence, Valence

All Listed Sponsors
lead

Centre Hospitalier de Valence

OTHER

NCT05491967 - Comparison of Vascular Risk in Patients Treated for Obstructive Sleep Apnea/Hypopnea Syndrome | Biotech Hunter | Biotech Hunter